Document Detail


ABO blood group, hypercoagulability, and cardiovascular and cancer risk.
MedLine Citation:
PMID:  22856614     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The antigens of the ABO system (A, B, and H determinants, respectively) consist of complex carbohydrate molecules. It has been known for nearly half a century that the ABO blood group exerts a major influence on plasma levels of the von Willebrand factor (VWF)-factor VIII (FVIII) complex and that normal group O individuals have significantly lower levels of VWF and FVIII than do non-O individuals. As a consequence, several investigators have studied the association between ABO blood group and the risk of developing bleeding or thrombotic events. A number of epidemiological studies have also analyzed the biologic relevance of this interaction by assessing whether the ABO blood group could influence human longevity through the regulation of VWF-FVIII plasma levels. In this review, the molecular mechanisms by which the ABO blood group determines plasma VWF and consequently, FVIII levels, the possible clinical implications, and the current knowledge on the association between the ABO blood group and the risk of developing certain cancers will be reviewed.
Authors:
Massimo Franchini; Emmanuel J Favaloro; Giovanni Targher; Giuseppe Lippi
Related Documents :
12068204 - T-pouch: a new valve design for a continent ileostomy.
6618714 - Origin and clinical relevance of musical murmurs.
11940794 - Augmentation of ventricular preload during treatment of cardiovascular collapse and car...
18611254 - Routine evaluation of left ventricular diastolic function by cardiovascular magnetic re...
8375564 - Further observations on the induction of immunity by hemolymph transfer in galleria mel...
10215214 - The relationship of myocardial stroke work to coronary flow velocity immediately after ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-3
Journal Detail:
Title:  Critical reviews in clinical laboratory sciences     Volume:  -     ISSN:  1549-781X     ISO Abbreviation:  Crit Rev Clin Lab Sci     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8914816     Medline TA:  Crit Rev Clin Lab Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Dipartimento di Medicina Trasfusionale ed Ematologia, Azienda Ospedaliera Carlo Poma , Mantova , Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vibration response imaging: a novel noninvasive tool for evaluating the initial therapeutic effect o...
Next Document:  Social inhibition as a mediator of neuroticism and depression in the elderly.